PolyPid Ltd.
$4.69
0%
2026-04-21 09:00:01
www.polypid.com
NCM: PYPD
Explore PolyPid Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$89.5 M
Current Price
$4.69
52W High / Low
$5.12 / $2.44
Stock P/E
—
Book Value
$0.6
Dividend Yield
—
ROCE
-226.3%
ROE
-3.66%
Face Value
—
EPS
$-2.09
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
69
Beta
1.46
Debt / Equity
25.48
Current Ratio
1.97
Quick Ratio
1.82
Forward P/E
-4.66
Price / Sales
—
Enterprise Value
$72.11 M
EV / EBITDA
-2.29
EV / Revenue
—
Rating
Strong Buy
Target Price
$12.25
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Lunai Bioworks Inc. | $0.34 | — | $12.33 M | — | 88.63% | -3.66% | $5.5 / $0.15 | $-0.56 |
| 2. | Vir Biotechnology, Inc. | $11.09 | — | $1.72 B | — | -52.69% | -45.73% | $10.94 / $4.16 | $5.49 |
| 3. | Ensysce Biosciences, Inc. | $0.48 | — | $4.49 M | — | -355% | -3.25% | $4.85 / $0.31 | $0.7 |
| 4. | MBX Biosciences, Inc. | $33.78 | — | $1.6 B | — | -26.53% | -27.76% | $44.89 / $7.09 | $8.22 |
| 5. | Agenus Inc. | $4.42 | 1,529.26 | $175.86 M | — | 21.26% | -0.04% | $7.34 / $1.6 | $-7.68 |
| 6. | Alaunos Therapeutics, Inc. | $2.84 | — | $6.71 M | — | -233.25% | -1.98% | $6.2 / $1.67 | $1.27 |
| 7. | ImageneBio, Inc. | $6 | — | $65.99 M | — | -34.18% | -68.91% | $18 / $3.94 | $11.91 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -8.53 M | -7.46 M | -9.4 M | -7.58 M | -8.22 M | — |
| Net Profit | -8.47 M | -7.45 M | -9.98 M | -8.27 M | -8.52 M | — |
| EPS in Rs | -0.44 | -0.39 | -0.52 | -0.43 | -0.45 | -1.22 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -32.97 M | -28.03 M | -22.87 M | -38.89 M |
| Net Profit | -34.17 M | -29.02 M | -23.86 M | -39.56 M |
| EPS in Rs | -1.79 | -1.52 | -1.25 | -2.07 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 22.31 M | 25.22 M | 15.37 M | 25.97 M |
| Total Liabilities | 11.33 M | 17.54 M | 17.47 M | 20.14 M |
| Equity | 10.97 M | 7.68 M | -2.1 M | 5.83 M |
| Current Assets | 15.23 M | 16.57 M | 6.07 M | 14.19 M |
| Current Liabilities | 7.74 M | 12.68 M | 7.29 M | 8.55 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -27.88 M | -21.96 M | -17.24 M | -34.32 M |
| Investing CF | -6.7 M | -0.33 M | 3.8 M | 16.57 M |
| Financing CF | 25.37 M | 32.42 M | 9.98 M | 16.43 M |
| Free CF | -28.09 M | -22.04 M | -17.43 M | -36.08 M |
| Capex | -0.21 M | -0.08 M | -0.2 M | -1.77 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -21.61% | 39.67% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-09-21 | 1:0.0333333 |